Fmr LLC Minerva Neurosciences, Inc. Transaction History

Fmr LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$1.34 - $1.85 $33 - $46	-25 Closed	0 $0
Q1 2025 May 12, 2025	BUY	$1.53 - $2.68 $38 - $67	25 New	25 $0
Q4 2024 Feb 13, 2025	BUY	$2.1 - $2.7 $0 - $0	0 New	0 $0
Q3 2024 Nov 13, 2024	BUY	$2.55 - $3.4 $0 - $0	0 New	0 $0
Q2 2023 Aug 11, 2023	BUY	$1.62 - $10.19 $796,628 - $5.01 Million	491,746 New	491,746 $4.49 Million
Q3 2022 Nov 10, 2022	SELL	$2.53 - $13.17 $55,293 - $287,830	-21,855 Reduced 43.6%	28,272 $261,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $7.68 $135,342 - $384,975	50,127 New	50,127 $166,000

1.94M

Ticker NERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,340,190
Market Cap $13.7M
Description
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone for the treatment of schizophrenia; and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein ...

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

Stay updated on Fmr LLC with notifications on news.